in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Indian pharma firm Aurobindo to spinoff unit, makes 2 acquisitions
4:08 AM MDT | August 11, 2013 | Natasha Alperowicz
The board of directors of Indian pharmaceuticals producer Aurobindo Pharma (Hyderabad) has approved a proposal to evaluate the spinoff of its injectable pharma business into a wholly owned subsidiary and to look for strategic alliances. Aurobindo Pharma currently manufactures injectables at 2 facilities located near Hyderabad. The board has also approved a proposal to acquire 60% in Celon Laboratories' (Hyderabad) manufacturing facility currently under construction for 156 million Indian rupee ($2.6 million). The facility will produce hormonal and oncology...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee